D’Urso, G.; Magliacano, A.; Manzo, M.; Pomes, M.V.; Iuliano, C.; Iasevoli, F.; Dell’Osso, B.; de Bartolomeis, A.
Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits. Brain Sci. 2024, 14, 338.
https://doi.org/10.3390/brainsci14040338
AMA Style
D’Urso G, Magliacano A, Manzo M, Pomes MV, Iuliano C, Iasevoli F, Dell’Osso B, de Bartolomeis A.
Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits. Brain Sciences. 2024; 14(4):338.
https://doi.org/10.3390/brainsci14040338
Chicago/Turabian Style
D’Urso, Giordano, Alfonso Magliacano, Marco Manzo, Mattia Vittorio Pomes, Carla Iuliano, Felice Iasevoli, Bernardo Dell’Osso, and Andrea de Bartolomeis.
2024. "Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits" Brain Sciences 14, no. 4: 338.
https://doi.org/10.3390/brainsci14040338
APA Style
D’Urso, G., Magliacano, A., Manzo, M., Pomes, M. V., Iuliano, C., Iasevoli, F., Dell’Osso, B., & de Bartolomeis, A.
(2024). Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits. Brain Sciences, 14(4), 338.
https://doi.org/10.3390/brainsci14040338
